SCHEMBL4614015

SCHEMBL4614015

Ic1cccc2cc3ccccc3cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.50
KDM4E B2RXH2 3/20 0.50
GAA P10253 2/20 0.50
HSD17B10 Q99714 6/20 0.44
HIF1A Q16665 4/20 0.44
CYP1B1 Q16678 1/20 0.44
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 4/20 0.40
ACHE P22303 2/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
AHR P35869 1/20 0.40
C1R P00736 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
HTR2A P28223 1/20 0.38
NQO1 P15559 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108395 1.00 ALDH1A1 (0.50) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL30903863 0.98 ALDH1A1 (0.48) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL31072226 0.98 ALDH1A1 (0.48) ALDH1A1KDM4EGAAHSD17B10HIF1A
Formaldehyde SCHEMBL28561333 0.93 ALDH1A1 (0.50) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL16723362 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL15768897 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL30838410 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL19230461 0.85 ALDH1A1 (0.39) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL10866681 0.82 C1R (0.45) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL19802369 0.82 ALDH1A1 (0.60) ALDH1A1HSD17B10HIF1ACYP1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151672-A1 DIRECTED BIOSYNTHESIS OF MODIFIED ANTHRAQUINONE-FUSED ENEDIYNES AS POTENTIAL CANCER THERAPEUTICS THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-18 WO claimed
CN-116836403-A Polycarboxylate superplasticizer with dynamic self-regulating and controlling capability and preparation method thereof 江苏奥莱特新材料股份有限公司 2023-10-03 CN claimed
CN-101768055-B Liquid crystal compound and preparation method thereof UNIV TSINGHUA 2013-03-27 CN claimed
CN-101768055-A Liquid crystal compound and preparation method thereof UNIV TSINGHUA 2010-07-07 CN claimed
CN-114583259-B Nonaqueous electrolyte for lithium ion secondary battery and lithium ion secondary battery 泰星能源解决方案有限公司 2024-11-12 CN disclosed
US-12136699-B2 Nonaqueous electrolyte solution of lithium ion secondary battery, and lithium ion secondary battery Prime Planet Energy & Solutions, Inc. (JP) 2024-11-05 US disclosed
US-20240301179-A1 POLYAMINO IODINATED COMPOUNDS AND RADIOPAQUE HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2024-09-12 US disclosed
WO-2024151672-A1 DIRECTED BIOSYNTHESIS OF MODIFIED ANTHRAQUINONE-FUSED ENEDIYNES AS POTENTIAL CANCER THERAPEUTICS THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-18 WO disclosed
US-20230380267-A1 COMPOUNDS FOR STRUCTURING FUNCTIONAL LAYERS OF ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-11-23 US disclosed
CN-116836403-A Polycarboxylate superplasticizer with dynamic self-regulating and controlling capability and preparation method thereof 江苏奥莱特新材料股份有限公司 2023-10-03 CN disclosed
CN-116675661-A Organic compound, light-emitting element, and synthesis method 株式会社半导体能源研究所 2023-09-01 CN disclosed
EP-4225006-A2 ORGANIC LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-08-09 EP disclosed
EP-0377634-A1 PROCESS FOR THE PREPARATION OF ARYL SULFIDES. EASTMAN KODAK CO (US) 1990-07-18 EP disclosed
EP-0236348-B1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-05-02 EP disclosed
WO-1989001463-A1 PROCESS FOR THE PREPARATION OF ARYL SULFIDES EASTMAN KODAK COMPANY (US) 1989-02-23 WO disclosed
US-4792634-A HEATING IODOAROMATIC COMPOUND WITH SULFUR EASTMAN KODAK COMPANY (US) 1988-12-20 US disclosed
EP-0236348-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS. EASTMAN KODAK CO (US) 1987-09-16 EP disclosed
US-4649216-A Carbonylation process for the production of aromatic acids EASTMAN KODAK COMPANY (US) 1987-03-10 US disclosed
WO-1987000829-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (US) 1987-02-12 WO disclosed
US-4631247-A Acetylene compounds as shelf life improvers for photoresist compositions containing organic iodides HERCULES INCORPORATED (US) 1986-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240301179-A1 POLYAMINO IODINATED COMPOUNDS AND RADIOPAQUE HYDROGELS FORMED THEREFROM ITK, IGF1R, THEM6 ALDH1A1 3485/4885KDM4E 4667/4885GAA 3786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.